Search Results 1601-1610 of 18396 for Capsule

  1. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    SER-109 is an MRT , containing live, purified Firmicutes spores. Administered via capsule, SER-109 has received Breakthrough Therapy and Orphan Drug ...

  2. Clinical trials - Oncology (Medical)

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  3. Clinical trials - Oncology (Medical)

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  4. Publications - Nayantara Coelho-Prabhu, M.B.B.S. - Mayo Clinic

    A novel blood-sensing capsule for rapid detection of upper GI bleeding: a prospective clinical trial. Gastrointest Endosc. 2024 May; 99 (5):712-720 Epub ...

  5. Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations - Mayo Clinic

    Ability to swallow capsules or tablets. Ability to comply with outpatient treatment, laboratory monitoring, and required clinic visits for the duration of ...

  6. Study of Treating Patients with Vestibular Schwannoma with Aspirin - Mayo Clinic

    Ability to swallow capsules. Exclusion Criteria: Use of aspirin (or aspirin containing products) more than four times in a single week within the last two ...

  7. Clinical trials - Oncology (Medical)

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  8. Covid Queries: Altered DNA and microchips - Mayo Clinic News Network

    Q: I've heard some theories circulating about the COVID-19 vaccine, including that it was developed to control the general population through microchip ...

  9. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Inability to swallow capsules, or disease significantly affecting gastrointestinal function such as malabsorption syndrome, resection of the complete small ...

  10. A Study of DKN-01 in Combination with Tislelizumab ± Chemotherapy in Patients with Gastric or Gastroesophageal Cancer - Mayo Clinic

    Diagnosis of HER2-positive G/GEJ adenocarcinoma. 2. Unable to swallow capsules or disease significantly affected gastrointestinal function such as ...